|Articles|October 14, 2019
Quantifying Quality Attributes of AAV Gene Therapy Vectors by SEC-UV-MALS-dRI
Author(s)Wyatt
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
2
2025 PharmSci 360 to Showcase Essential AI Integration and Emerging Technologies
3
Pharma Tariff FAQ: Costs, Supply Chains, Policy for 2025
4
Meeting Global Demand and Delivering Faster, More Reliable Service
5
